Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
about
Letrozole sensitizes breast cancer cells to ionizing radiationPostmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available dataManaging breast cancer in younger women: challenges and solutionsHypofractionated whole breast radiotherapy: current perspectivesPostmastectomy radiation therapy: an overview for the practicing surgeonAltering the response to radiation: sensitizers and protectorsPractical clinical trials in psychopharmacology: a systematic reviewManagement of Axilla in 2015 in Indian ScenarioIndividual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsCurrent role of modern radiotherapy techniques in the management of breast cancerEvaluation of the radiotherapy treatment planning in the presence of a magnetic valve tissue expander.Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.Influence of the presence of tissue expanders on energy deposition for post-mastectomy radiotherapyBreast cancer (non-metastatic)Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer.Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data.Anthracycline and concurrent radiotherapy as adjuvant treatment of operable breast cancer: a retrospective cohort study in a single institutionRole of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer.Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases.Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study.Medical advice columns give both good and bad counselEffects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes.Adjuvant irradiation for breast cancer. Treatment plans need to be made with better anatomical information.Cardiovascular mortality after radiotherapy for breast cancer. Study showed only estimates of use of adjuvant radiotherapy.Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancerPost-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.Role of axillary surgery in early breast cancer: review of the current evidence.Advances in managing breast cancer: a clinical updateLocal recurrence after mastectomy and adjuvant CMF: implications for adjuvant radiation therapy.Adjuvant radiotherapy in breast cancer--the treatment of lymph node areas.Metabolic differences in breast cancer stem cells and differentiated progeny.Axillary lymph node dissection in breast cancer--current status and controversies, alternative strategies and future perspectives.Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care systemDisparities in the use of radiation therapy in patients with local-regionally advanced breast cancer.Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy.The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience.Use of thoracodorsal artery perforator flaps to enhance outcomes in alloplastic breast reconstructionRadiotherapy in the management of early breast cancer.Risk factors for locoregional recurrence after postmastectomy radiotherapy in breast cancer patients with four or more positive axillary lymph nodes.
P2860
Q24797004-A86AD560-8805-462C-A6CC-E2E0FBC0FCA2Q26769835-4C1817AE-98B5-4895-B62A-C846572A72D7Q26771184-7EF65389-4BA3-47E0-9806-18B17190460CQ26775841-BB0BBECB-6D05-428F-BAD6-1BFE126FB8F3Q26823624-8439055D-83A1-435C-86DF-C6C0D43D1A26Q26865377-2AB42DFD-6A0B-402D-B719-A3B881E061ECQ27021467-525B839D-27B4-49BC-B883-0B6DA1FE71E3Q28079495-B78B0906-7B17-4E85-B6A1-7755AF040684Q28302352-4EA79F4D-123B-4706-A3EC-257214F732C0Q28972351-3B90238B-272D-4EA8-90EB-B146FFE67578Q30418156-4D303767-8AA0-4563-9BA9-3D74809EBC0CQ30422607-4B7B5C96-8C34-4FE6-ADC5-0C5060938FF4Q30458295-E8DCE78F-99C9-4910-A52D-1B8006444F5CQ33446778-173C1B69-C522-466E-8295-D1CDAFC6A693Q33685009-8D6A7716-605B-41E6-AB35-628F26EB869FQ33694686-275A571B-250D-4F63-8FCF-75ACE9B4CB8AQ33710117-64AD7290-5A9F-41B5-8507-02CD213E31E1Q33710557-0F281F4A-4751-401E-9B69-914B654EF2B8Q33749014-76EE5B61-AA27-45D5-834F-DCE96A4D621EQ33779707-BF17BC94-85D7-4546-B759-484B08E0D4C0Q33799651-7197592C-A13C-4597-86F9-E48B2550D37FQ33802459-B6E3DA80-E8A2-4CFA-8F05-A7736922296FQ33802889-E45CF4A2-AD44-4C9B-A674-CAC00362EE71Q33814894-D807AFB8-E059-45AB-81A6-04684CF1E30CQ33897593-F719AA3A-2F98-4310-AD7F-52A979B1BA4DQ33946372-E01A794C-AD18-4A19-9723-0BF2DDEA23D2Q33956174-57FE8E9C-348A-492B-BEAB-745FF12247A8Q33972653-0E779CF1-0030-434E-91BF-48C0D3B595C6Q34019904-921DB2F8-2705-4F04-9DDC-404EFC961887Q34025384-E9D0DD0A-C3A2-445E-904C-D19EBC471741Q34033287-278529AD-FAB0-4669-8AFD-8F9151AE4E80Q34039960-2EC71D88-2BEF-4119-9003-EC9C1EA65567Q34065818-4B072248-3DEE-4CD1-92C5-1726E375D0EAQ34107526-C4832990-E5D1-4283-875D-A2DD214BF683Q34158859-A5AA4CA1-0214-4B40-80FA-8878EC85138DQ34181534-0CC84F7F-E553-4CE1-8E54-46D863694424Q34205744-72FF0745-35ED-4392-ADA2-815D3F60EFFCQ34239052-71A90819-7FA5-4D1F-812B-57D2AB9A70BDQ34247346-CE449843-D62E-4DF1-93B8-58A0F1B43DEDQ34305933-9131CFEF-F9DF-44DE-A3B2-79DC4AF0FB69
P2860
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Postoperative radiotherapy in ...... oup DBCG 82c randomised trial.
@en
Postoperative radiotherapy in ...... oup DBCG 82c randomised trial.
@nl
type
label
Postoperative radiotherapy in ...... oup DBCG 82c randomised trial.
@en
Postoperative radiotherapy in ...... oup DBCG 82c randomised trial.
@nl
prefLabel
Postoperative radiotherapy in ...... oup DBCG 82c randomised trial.
@en
Postoperative radiotherapy in ...... oup DBCG 82c randomised trial.
@nl
P2093
P1433
P1476
Postoperative radiotherapy in ...... oup DBCG 82c randomised trial.
@en
P2093
B B Rasmussen
C C Gadeberg
H T Mouridsen
J Overgaard
M Andersson
M B Jensen
M Blichert-Toft
P304
P356
10.1016/S0140-6736(98)09201-0
P407
P577
1999-05-01T00:00:00Z